Astex Pharmaceuticals Ltd.

Otsuka Pharmaceutical Co. Ltd. is paying up to $1.3bn for private US-based drug discovery specialist Jnana Therapeutics Inc. , in a deal that will give the Japanese major access to platform technolo

In gaining the first US approval for an AKT inhibitor in Truqap (capivasertib), AstraZeneca PLC has comprehensively trounced Roche Holding AG , whose similarly-acting ipatasertib once looked like a

The University of Texas MD Anderson Cancer Center and US/UK biotech Replay announced on 14 February that they are launching a new company, Syena, to advance research conducted at the cancer center o

Merck & Co., Inc. is well aware that it needs to begin planning for its post-Keytruda future, with the blockbuster anti-PD-1 agent slated to lose patent protection in 2028, but with its plans for a l